Kymera Therapeutics Stock Price History
| KYMR Stock | USD 46.86 0.88 1.91% |
Below is the normalized historical share price chart for Kymera Therapeutics extending back to August 21, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Kymera Therapeutics stands at 46.86, as last reported on the 29th of November, with the highest price reaching 47.73 and the lowest price hitting 46.05 during the day.
If you're considering investing in Kymera Stock, it is important to understand the factors that can impact its price. Currently, Kymera Therapeutics is very steady. Kymera Therapeutics has Sharpe Ratio of 0.0212, which conveys that the firm had a 0.0212% return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Kymera Therapeutics, which you can use to evaluate the volatility of the firm. Please verify Kymera Therapeutics' Standard Deviation of 3.08, mean deviation of 2.37, and Risk Adjusted Performance of 0.0028 to check out if the risk estimate we provide is consistent with the expected return of 0.0658%.
As of 11/29/2024, Stock Based Compensation is likely to grow to about 45.3 M, while Total Stockholder Equity is likely to drop slightly above 278.6 M. . At this time, Kymera Therapeutics' Price Book Value Ratio is relatively stable compared to the past year. As of 11/29/2024, Price Earnings To Growth Ratio is likely to grow to 1.00, while Price Earnings Ratio is likely to drop (10.62). Kymera Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 21st of August 2020 | 200 Day MA 41.1094 | 50 Day MA 46.9081 | Beta 2.219 |
Kymera |
Sharpe Ratio = 0.0212
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | KYMR | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.1 actual daily | 27 73% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Kymera Therapeutics is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kymera Therapeutics by adding it to a well-diversified portfolio.
Price Book 3.3988 | Enterprise Value Ebitda (9.49) | Price Sales 34.6596 | Shares Float 44 M | Wall Street Target Price 57.7647 |
Kymera Therapeutics Stock Price History Chart
There are several ways to analyze Kymera Stock price data. The simplest method is using a basic Kymera candlestick price chart, which shows Kymera Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 24, 2024 | 52.4 |
| Lowest Price | November 15, 2024 | 41.96 |
Kymera Therapeutics November 29, 2024 Stock Price Synopsis
Various analyses of Kymera Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Kymera Stock. It can be used to describe the percentage change in the price of Kymera Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Kymera Stock.| Kymera Therapeutics Price Daily Balance Of Power | 0.52 | |
| Kymera Therapeutics Price Rate Of Daily Change | 1.02 | |
| Kymera Therapeutics Price Action Indicator | 0.41 |
Kymera Therapeutics November 29, 2024 Stock Price Analysis
Kymera Stock Price History Data
The price series of Kymera Therapeutics for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 has a statistical range of 10.44 with a coefficient of variation of 5.27. The daily prices for the period are spread out with arithmetic mean of 46.89. The median price for the last 90 days is 46.86.| Open | High | Low | Close | Volume | ||
11/29/2024 | 46.05 | 47.73 | 46.05 | 46.86 | ||
| 11/27/2024 | 46.05 | 47.73 | 46.05 | 46.86 | 388,380 | |
| 11/26/2024 | 46.92 | 47.57 | 44.75 | 45.98 | 967,461 | |
| 11/25/2024 | 45.41 | 48.29 | 45.38 | 47.02 | 545,608 | |
| 11/22/2024 | 43.70 | 45.94 | 43.28 | 44.98 | 559,363 | |
| 11/21/2024 | 44.05 | 44.81 | 42.87 | 43.51 | 510,847 | |
| 11/20/2024 | 42.75 | 44.11 | 42.10 | 44.05 | 385,462 | |
| 11/19/2024 | 42.09 | 42.89 | 41.50 | 42.84 | 376,677 | |
| 11/18/2024 | 42.03 | 43.08 | 41.12 | 42.41 | 405,191 | |
| 11/15/2024 | 45.00 | 45.45 | 41.50 | 41.96 | 827,514 | |
| 11/14/2024 | 48.70 | 49.09 | 45.89 | 45.95 | 413,689 | |
| 11/13/2024 | 50.79 | 51.15 | 48.63 | 48.63 | 280,288 | |
| 11/12/2024 | 51.49 | 52.49 | 49.12 | 50.00 | 308,735 | |
| 11/11/2024 | 51.97 | 53.23 | 51.45 | 51.84 | 392,413 | |
| 11/08/2024 | 49.91 | 51.13 | 49.39 | 50.95 | 300,186 | |
| 11/07/2024 | 49.52 | 50.99 | 48.58 | 49.86 | 439,692 | |
| 11/06/2024 | 49.93 | 51.14 | 48.47 | 49.48 | 683,480 | |
| 11/05/2024 | 46.98 | 48.88 | 46.35 | 47.69 | 345,799 | |
| 11/04/2024 | 46.10 | 47.93 | 45.16 | 47.07 | 303,479 | |
| 11/01/2024 | 47.10 | 47.65 | 45.20 | 46.47 | 432,609 | |
| 10/31/2024 | 44.75 | 46.98 | 42.62 | 46.17 | 747,821 | |
| 10/30/2024 | 48.12 | 48.57 | 47.26 | 47.67 | 293,720 | |
| 10/29/2024 | 48.53 | 49.16 | 47.75 | 48.49 | 356,814 | |
| 10/28/2024 | 49.01 | 50.29 | 48.84 | 49.08 | 324,176 | |
| 10/25/2024 | 49.03 | 49.53 | 47.07 | 47.99 | 430,325 | |
| 10/24/2024 | 48.95 | 49.79 | 48.37 | 48.73 | 282,022 | |
| 10/23/2024 | 48.25 | 49.33 | 47.50 | 48.76 | 561,263 | |
| 10/22/2024 | 46.48 | 48.58 | 45.75 | 48.37 | 305,974 | |
| 10/21/2024 | 46.23 | 46.89 | 45.54 | 46.56 | 281,501 | |
| 10/18/2024 | 46.58 | 46.98 | 45.71 | 46.41 | 222,936 | |
| 10/17/2024 | 48.89 | 49.42 | 46.18 | 46.25 | 290,612 | |
| 10/16/2024 | 45.10 | 49.17 | 44.66 | 49.02 | 371,264 | |
| 10/15/2024 | 46.43 | 46.43 | 44.35 | 44.80 | 389,564 | |
| 10/14/2024 | 44.74 | 46.50 | 44.74 | 46.05 | 193,401 | |
| 10/11/2024 | 43.18 | 45.29 | 43.18 | 45.02 | 290,605 | |
| 10/10/2024 | 42.61 | 43.93 | 42.36 | 43.24 | 255,194 | |
| 10/09/2024 | 43.25 | 43.44 | 42.00 | 43.34 | 371,382 | |
| 10/08/2024 | 42.50 | 43.90 | 42.41 | 43.04 | 416,339 | |
| 10/07/2024 | 42.80 | 42.94 | 41.61 | 42.21 | 430,042 | |
| 10/04/2024 | 44.07 | 44.19 | 42.71 | 43.06 | 329,073 | |
| 10/03/2024 | 44.75 | 45.32 | 43.00 | 43.41 | 450,581 | |
| 10/02/2024 | 45.93 | 46.25 | 44.75 | 45.00 | 482,535 | |
| 10/01/2024 | 46.96 | 47.48 | 46.02 | 46.57 | 475,627 | |
| 09/30/2024 | 48.38 | 49.66 | 46.78 | 47.33 | 561,680 | |
| 09/27/2024 | 49.84 | 50.60 | 48.33 | 48.69 | 243,186 | |
| 09/26/2024 | 52.95 | 53.27 | 48.62 | 49.47 | 335,291 | |
| 09/25/2024 | 53.00 | 53.14 | 51.84 | 51.93 | 509,290 | |
| 09/24/2024 | 50.18 | 52.60 | 49.44 | 52.40 | 751,974 | |
| 09/23/2024 | 50.00 | 51.26 | 48.74 | 49.98 | 937,257 | |
| 09/20/2024 | 49.04 | 50.25 | 48.05 | 49.79 | 1,245,907 | |
| 09/19/2024 | 48.34 | 50.69 | 47.57 | 49.03 | 484,557 | |
| 09/18/2024 | 47.51 | 48.33 | 45.67 | 46.44 | 342,618 | |
| 09/17/2024 | 48.73 | 49.20 | 47.25 | 47.30 | 327,736 | |
| 09/16/2024 | 46.42 | 49.15 | 46.00 | 48.48 | 429,407 | |
| 09/13/2024 | 45.07 | 46.47 | 44.53 | 46.08 | 381,224 | |
| 09/12/2024 | 44.70 | 46.03 | 44.20 | 44.72 | 251,621 | |
| 09/11/2024 | 46.49 | 46.90 | 44.65 | 44.77 | 362,959 | |
| 09/10/2024 | 46.56 | 46.93 | 44.95 | 46.88 | 220,688 | |
| 09/09/2024 | 46.06 | 47.02 | 45.66 | 46.24 | 298,864 | |
| 09/06/2024 | 47.04 | 48.53 | 43.90 | 45.40 | 276,784 | |
| 09/05/2024 | 46.29 | 46.69 | 45.34 | 46.60 | 263,845 |
About Kymera Therapeutics Stock history
Kymera Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kymera is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kymera Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kymera Therapeutics stock prices may prove useful in developing a viable investing in Kymera Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 58.4 M | 44.4 M | |
| Net Loss | -139.3 M | -132.4 M |
Kymera Therapeutics Quarterly Net Working Capital |
|
Kymera Therapeutics Stock Technical Analysis
Kymera Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Kymera Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Kymera Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Kymera Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kymera to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0028 | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.49) | |||
| Treynor Ratio | (0.01) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Kymera Stock Analysis
When running Kymera Therapeutics' price analysis, check to measure Kymera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kymera Therapeutics is operating at the current time. Most of Kymera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Kymera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kymera Therapeutics' price. Additionally, you may evaluate how the addition of Kymera Therapeutics to your portfolios can decrease your overall portfolio volatility.